drugset / Trial / NCT00930072

Safety Study of Cervical Sympathetic Block for Cerebral Vasospasm Following Aneurysmal Subarachnoid Hemorrhage

NCT00930072

Phase 2 Terminated 7 enrolled University of Washington
RandomizedParallel-groupDouble-blindTreatment

Summary

To evaluate the feasibility of performing a cervical sympathetic block in patients with severe cerebral vasospasm involving the anterior cerebral circulation following aneurysmal SAH.

Timeline

Start
2009-04
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 0.5 %
Subject Clonidine Other / unclassified 50 ug